Recent Advances in Etiopathogenesis of Dilated Cardiomyopathy: Which Relevance for the Clinical Cardiologist?

  • A. Gavazzi
  • M. Ponzetta
  • C. Inserra
  • M. Giraldi
  • R. Sebastiani
  • C. Campana
  • A. Raisaro
  • M. Laudisa
  • E. Colombi
  • B. Dal Bello
  • E. Arbustini
Conference paper


Cardiomyopathies are no longer considered as heart muscle diseases of unknown cause [1], but are defined as diseases of the myocardium associated with cardiac dysfunction, and classified by the dominant pathophysiology or, if possible, by etiological and pathogenetic factors [2].


Dilate Cardiomyopathy Endomyocardial Biopsy Idiopathic Dilate Cardiomyopathy Giant Cell Myocarditis Heart Muscle Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies (1980) Br Heart J 44:672–673CrossRefGoogle Scholar
  2. 2.
    Richardson P, McKenna WJ, Bristow M, Maisch B, Mautner B, O’ Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842PubMedCrossRefGoogle Scholar
  3. 3.
    Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47:525–531PubMedCrossRefGoogle Scholar
  4. 4.
    Michel VV, Driscoll DJ, Miller FA (1985) Familial aggregation of idiopathic dilated cardiomyopathy. Am J Cardiol 55:1232–1233CrossRefGoogle Scholar
  5. 5.
    Michels VV, Moll PP, Miller FA, TajiK AJ, Chu JS, Briscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD (1992) The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326:77–82PubMedCrossRefGoogle Scholar
  6. 6.
    Keeling PJ, Gang G, Smith G, Seo H, Bent SE, Murday V, Caforio ALP, McKenna WJ (1995) Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 73:417–421PubMedCrossRefGoogle Scholar
  7. 7.
    Fragola PV, Autore A, Picelli A, Sommariva L, Cannata D, Sangiorgi M (1988) Familial dilated cardiomyopathy. Am Heart J 115:912–914CrossRefGoogle Scholar
  8. 8.
    Griffin ML, Hernandez A, Martin TC, Goldring D, Bolman RM, Spray TL, Strauss AW (1988) Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 11:139–144PubMedCrossRefGoogle Scholar
  9. 9.
    Valantine HA, Hunt SA, Fowler MB, Billingham ME, Schoeder JS (1989) Frequency of familial nature of dilated cardiomyopathy and usefulness of cardiac transplantation in this subset. Am J Cardiol 63:959–963PubMedCrossRefGoogle Scholar
  10. 10.
    Keren A, Gottlieb S, Tzivoni D, Stern S, Yarom R, Billingham ME, Popp RL (1990) Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation. Circulation 81:506–517Google Scholar
  11. 11.
    Mestroni L, Miani D, Di Lenarda A, Silvestri F, Bussani R, Filippi G (1990) Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol 65:1449–1453PubMedCrossRefGoogle Scholar
  12. 12.
    Zachara E, Caforio ALP, Carboni GP, Pellegrini A, Pompili A, Del Porto G, Scarra A, Bosman C, Boldrini R, Prati Pl, McKenna WJ (1993) Familial aggregation of idiopathic dilated cardiomyopathy: clinical features and pedigree analysis in 14 families. Br Heart J 69:129–135PubMedCrossRefGoogle Scholar
  13. 13.
    Mestroni L, Milasin J, Vatta M, Pinamonti B, Sinagra G, Rocco C, Matulic M, Falaschi A, Giacca M, Camerini F and the heart muscle disease study group (1996) Genetic factors in dilated cardiomyopathy. Arch Mal Coeur 89:15PubMedGoogle Scholar
  14. 14.
    Gavazzi A, De Maria R, Renosto G, Moro A, Borgia M, Caroli A, Castelli G, Ciaccheri M, Pavan D, De Vita C, Baroldi G, Camerini F (1993) The spectrum of left ventricular size in dilated cardiomyopathy: Clinical correlates and prognostic implications. Am Heart J 125:410–422PubMedCrossRefGoogle Scholar
  15. 15.
    Mestroni L, Krajinovic M, Severini GM, Pinamonti B, Di Lenarda A, Giacca M, Falaschi A Camerini F (1994) Familial dilated cardiomyopathy. Br Heart J 72 [Suppl 6]:S35–S41PubMedCrossRefGoogle Scholar
  16. 16.
    Zeviani M, Gellera C, Antozzi C, Rimoldi M, Morandi L, Villani F, Tiranti V, Di Donato S (1991) Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA Leu (UUR). Lancet 338:143–147PubMedCrossRefGoogle Scholar
  17. 17.
    Berko B, Swift M (1987) X-linked dilated cardiomyopathy. N Engl J Med 316:1186–1191PubMedCrossRefGoogle Scholar
  18. 18.
    Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker PB 3rd, Cody RJ, Fishman MC (1994) A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nature Genet 7:546–551PubMedCrossRefGoogle Scholar
  19. 19.
    Durand JB, Bachinski LL, Bieling LC, Czernuszewicz GZ, Abche AB, Tao Yu Q, Tapscot T, Hill R, Ifegwu J, Marian AJ, Brugada R, Daiger S, Gregoritch JM, Anderson JL, Quinones M, Towbin JA, Roberts R (1995) Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation 92:3387–3389PubMedCrossRefGoogle Scholar
  20. 20.
    Olson TM, Keating MT (1996) Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 97:528–532PubMedCrossRefGoogle Scholar
  21. 21.
    Krajinovic M, Pinamonti B, Sinagra GF, Batta M, Severini GM, Milasin J, Falaschi A, Camerini F, Giacca M, Mestroni L and the heart muscle disease study group (1995) Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Gen 57:846–852Google Scholar
  22. 22.
    Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A, Melis MA (1993) Deletion of the dystrophin muscle-promoter region associated wiyh X-linked dilated cardiomyopathy. N Engl J Med 329:921–925PubMedCrossRefGoogle Scholar
  23. 23.
    Caforio ALP, Stewart JT, Bonifacio E, Burke M, Davies MJ, McKenna WJ, Bottazzo GF (1990) Inappropiate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmunity 3:187–200Google Scholar
  24. 24.
    Ronnblom LE, Forsberg H, Evrin PE (1991) Increase level of HDL-DR expressing T lynphocytes in peripheral blood from patients with idiopathic dilated cardiomyopathy. Cardiology 78:161–167PubMedCrossRefGoogle Scholar
  25. 25.
    Carlquist JF, Menlove RL, Murray MB, O’Connell JB, Anderson JL (1991) HLA Class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Circulation 83:515–522PubMedCrossRefGoogle Scholar
  26. 26.
    Zerbe TR, Kaufmann C, Colson Y, Duquesnoy R (1988) Associations of HLA-A,B, DR antigens with primary disease in cardiac allograft recipients. Am J Cardiol 61:1359–1361PubMedCrossRefGoogle Scholar
  27. 27.
    Limas CJ, Limas C (1989) HLA antigens in idiopathic dilated cardiomyopathy. Br Heart J 62:379–383PubMedCrossRefGoogle Scholar
  28. 28.
    Komajda M, Raffoux C, Salame E, Colombani J, Grosgogeat Y, Cabrol C, Dausset J (1987) HLA A-B and DR antigens in dilated cardiomyopathy. Arch Mal Coeur Vaiss 80:1233–1237PubMedGoogle Scholar
  29. 29.
    Arbustini E, Gavazzi A, Pozzi R, Grasso M, Pucci A, Campana C, Graziano G; Martinetti M, Cuccia M, Salvaneschi-L (1989) The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes. Am J Cardiol 64:991PubMedCrossRefGoogle Scholar
  30. 30.
    Schultheiss HP (1987) The mitochondrium as antigen in inflammatory heart disease. Eur Heart J 8:203–210CrossRefGoogle Scholar
  31. 31.
    Michels VV, Poll PP, Rodeheffer RJ, Miller FA Jr, Tajik AJ, Burnett-JC Jr, Driscoll DJ, Thibodeau SN, Ansari AA, Herskowitz A (1994) Circulating heart autoantibodies in familial as compared with non familial idiopathic dilated cardiomyopathy. Mayo Clin Proc 69:24–27PubMedGoogle Scholar
  32. 32.
    Limas CJ, Goldemberg IF, Limas C (1989) Autoantibodies against beta-adrenoceptors function in human dilated cardiomyopathy. Circ Res 64:97–103PubMedCrossRefGoogle Scholar
  33. 33.
    Sindhwani R, Yuen J (1994) Genetic basis of myocarditis: a paradigm based on myosin heavy chain polymorphisms. Heart Failure 2:12–25Google Scholar
  34. 34.
    Caforio ALP, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF (1990) Novel organ-specific circulating cardiac antibodies in dilated cardiomyopathy. J Am Coll Cardiol 15:1527–1534PubMedCrossRefGoogle Scholar
  35. 35.
    Caforio ALP, Goldman JH, Baig MK (1997) Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 77:62PubMedGoogle Scholar
  36. 36.
    Caforio LP, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ (1994) Autoimmunity in dilated cardiomyopathy: evidence from family studies. Lancet 344:773–777PubMedCrossRefGoogle Scholar
  37. 37.
    Matsumori A, Kawai C (1982) An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 66:355PubMedCrossRefGoogle Scholar
  38. 38.
    O’Connell JB, Mason JW (1989) Diagnosing and treating active myocarditis. West J Med 150:431–435PubMedGoogle Scholar
  39. 39.
    Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL (1994) The cause of dilated cardiomyopathy: a clinicapathologic review of 673 consecutive patients. J Am Coll Cardiol 23:586–590PubMedCrossRefGoogle Scholar
  40. 40.
    O’Connell JB (1992) Endomyocardial biopsy in the diagnosis and treatment of myocarditis. In: Fowles RE (ed) Cardiac biopsy. Futura Publishing Inc, Mount Kisko NY, pp 165–179Google Scholar
  41. 41.
    Aretz HT, Billingham ME, Edwars WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ (1987) Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14PubMedGoogle Scholar
  42. 42.
    Mason JW, O’Connel JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE and the myocarditis treatment trial investigators (1995) A clinical trial of immunosoppressive therapy for myocarditis. N Engl J Med 333:269–275PubMedCrossRefGoogle Scholar
  43. 43.
    Arbustini E, Gavazzi A, Dal Bello B, Morbini P, Campana C, Diegoli M, Grasso M, Fasani R, Banchieri N, Porcu E, Pilotto A, Ponzetta M, Bellini O, Lucreziotti S, Viganò M (1997) Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up. G Ital Cardiol 27:209–223PubMedGoogle Scholar
  44. 44.
    Kuhl U, Noutsias M, Schultheiss HP (1995) Immunohistochemistry in dilated cardiomyopathy. Eur Heart J 16 [Suppl O]:100–106PubMedCrossRefGoogle Scholar
  45. 45.
    Strauer BE, Kandolf R, Mall G, Maisch B, Mertens T, Schwatzkopff B, Schultheiss HP (1996) Myocarditis — Cardiomyopathy. Consensus Report of the German Association for Internal Medicine. Acta Cardiologica 51 (4):347–371PubMedGoogle Scholar
  46. 46.
    Caforio ALP, Goldman JH, Haven AJ, Baig MK, Dalla Libera L, McKenna WJ, and the Myocarditis Treatment Trial Investigators (1997) Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. Eur Heart J 18:270–275PubMedCrossRefGoogle Scholar
  47. 47.
    Kuhl U, Strauer BE, Schultheiss HP (1994) Methylprednisolone in chronic myocarditis. Br Heart J 72 [Suppl]:S30–S34CrossRefGoogle Scholar
  48. 48.
    Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, O.Cannon R, Ailing D, Wittes JT, Ferrans WJ, Rodriguez ER, Fauci AS (1989) A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321:1061–1069PubMedCrossRefGoogle Scholar
  49. 49.
    Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM (1989) Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy. Am Heart J 117:876–882PubMedCrossRefGoogle Scholar
  50. 50.
    Cambridge G, MacArthur CGC, Waterstone AP, Goodwin GF, Oakley CN (1979) Antibodies to Coxackie B viruses in congestive cardiomyopathy. Br Heart J 41:692–696PubMedCrossRefGoogle Scholar
  51. 51.
    Woodroof JF (1980) Viral myocarditis: a review. Am J Pathol 101:427–479Google Scholar
  52. 52.
    Bowles N, Richardson P, Olsen E, Archard L (1986) Detection of Coxackie-B-virusspecific RNA sequences in myocardial biopsy samples from patients with dilated cardiomyopathy and myocarditis. Lancet 1:1120–1123PubMedCrossRefGoogle Scholar
  53. 53.
    Kandolf R, Hofschneider PH (1989) Enterovirus-induced cardiomyopathy. In: Notkins AL, Oldstone MBA, (eds) Concepts in viral pathogenesis III. Springer-Verlag, New York pp 282–290CrossRefGoogle Scholar
  54. 54.
    Archard LC, Bowles NE, Cunningam L, Freeke CA, Morgan Capner P, Olsen EGS, Banner NR, Rose ML, Yacoub MH, Meany BT, Richardson PJ, (1990) Enterovirus RNA sequences in hearts with dilated cardiomyopathy: a pathogenetic link between virus infection and dilated cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF, (eds) Advances in cardiomyopathy. Springer-Verlag, Berlin, pp 194–198CrossRefGoogle Scholar
  55. 55.
    Tracy S, Wiegand V, McManus B, Gauntt C, Pallansch M, Beck M, Chapman N (1990) Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. J Am Coll Cardiol 15:1688–1694PubMedCrossRefGoogle Scholar
  56. 56.
    Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC (1990) Detection of Enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82:8–16PubMedCrossRefGoogle Scholar
  57. 57.
    Cochrane HR, May FEB, Ashcroft T, Dark JH (1991) Enteroviruses and idiopathic dilated cardiomyopathy. J Pathol 163:129–131PubMedCrossRefGoogle Scholar
  58. 58.
    Weiss LM, Liu XF, Chang KL, Billingham ME (1992) Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissue. J Clin Invest 90:156–159PubMedCrossRefGoogle Scholar
  59. 59.
    Grasso M, Arbustini E, Silini E, Diegoli M, Percivalle E, Ratti G, Bramerio M, Gavazzi A, Viganò M, Milanesi G (1992) Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polimerase chain reaction. Am J Cardiol 69:658–664PubMedCrossRefGoogle Scholar
  60. 60.
    Keeling PJ, Jeffery S, Caforio ALP, Taylor R, Bottazzo GF, Davies MJ, McKenna WJ (1992) Similar prevalence of enteroviral genome in myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br Heart J 68:554–559PubMedCrossRefGoogle Scholar
  61. 61.
    Satoh M, Tamura G, Segawa I, Hiramori K, Satodate R (1994) Enteroviral RNA in dilated cardiomyopathy. Eur Heart J 15:934–939PubMedGoogle Scholar
  62. 62.
    Giacca M, Severini GM, Mestroni L, Salvi A, Lardieri G, Falaschi A, Camerini F (1994) Low frequency of detection of enterovirus RNA in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy by nested polymerase chain reaction. J Am Coll Cardiol 24:10–33CrossRefGoogle Scholar
  63. 63.
    Figulla HR, Stille-Siegener M, Mall G, Heim A, Kreuzer H (1995) Myocardial enterovirus infection with left ventricular dysfuction: a benign disease compared with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 25:1170–1175PubMedCrossRefGoogle Scholar
  64. 64.
    Bowles NE, Rose ML, Taylor P, Banner NR, Morgan Capner P, Cunningham L, Archard LC, Yacoub MH (1989) Persistence of Enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80:1128–1136PubMedCrossRefGoogle Scholar
  65. 65.
    Archard LC, Bowles NE, Cunningham L, Freeke CA, Olsen EG, Rose ML, Meany B, Why HJ, Richardson PJ (1991) Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J 12 [Suppl D]:56–59PubMedCrossRefGoogle Scholar
  66. 66.
    Why HG.F, Meany BT, Richardson PJ (1994) Clinical and prognostic significance of detection of enteroviral rna in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89:2582–2589PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • A. Gavazzi
  • M. Ponzetta
  • C. Inserra
  • M. Giraldi
  • R. Sebastiani
  • C. Campana
  • A. Raisaro
  • M. Laudisa
  • E. Colombi
  • B. Dal Bello
  • E. Arbustini

There are no affiliations available

Personalised recommendations